A Lot Of Work To Be Done On Covid-19 Antibodies, Says Sauer Of Johns Hopkins

‘A Lot of Work to Be Done’ on Covid-19 Antibodies, Says Sauer of Johns Hopkins

Bloomberg Television

Experts discuss COVID-19 at Johns Hopkins Carey Business School

Johns Hopkins University

Still Lots to Learn on How Genetics Impact Covid-19: Johns Hopkins

Bloomberg Television

Covid-19: Johns Hopkins Sees ‘Great Hope’ in Antibodies Research

Bloomberg Television

Covid to Require Varying Degrees of Restrictions: Johns Hopkins’ Sauer

Bloomberg Television

More Learning Needed on Virus Mortality Rates, Johns Hopkins' Sauer Says

Bloomberg Television

Covid-19 Drug Treatment ‘Absolutely Promising’: Johns Hopkins’ Sauer

Bloomberg Television

Can Antibodies be Used to Treat or Prevent COVID-19?

Johns Hopkins Bloomberg School of Public Health

Coronavirus Testing Still Has a Long Way to Go: Johns Hopkins’ Sauer

Bloomberg Television

Johns Hopkins’ Sauer Sees ‘Cautious Optimism’ on Vaccines

Bloomberg Television

Covid-19 Messaging Must Be Founded in Science: Johns Hopkins’s Sauer

Bloomberg Television

Covid-19 Showing Long-Term Health Impact: Johns Hopkins

Bloomberg Television

No Holy Grail for Covid-19 Treatments: Johns Hopkins

Bloomberg Television

Lessons Learned from COVID-19 and What’s Next

Johns Hopkins Medicine

Covid-19 Fight Needs More Antibody, Plasma Data: Johns Hopkins

Bloomberg Television

Vaccine for All ‘Decent Amount’ of Weeks Away, Johns Hopkins' Sauer Says

Bloomberg Television

An Emergency Medicine Expert Answers More of Your COVID-19 Questions

Johns Hopkins Bloomberg School of Public Health

Johns Hopkins Congressional Briefing on the Coronavirus Resource Center - Oct. 6, 2021

Johns Hopkins University

The Johns Hopkins 30-Minute COVID-19 Briefing: Dec. 11, 2020

Johns Hopkins University

We Can't Vaccinate Our Way Out of the Pandemic: Johns Hopkins' Adalja

Bloomberg Television